| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | 0.041 | 0.2 |
| mRNA | BRD8899 | CTRPv2 | pan-cancer | AAC | -0.049 | 0.2 |
| mRNA | BMS-536924 | CTRPv2 | pan-cancer | AAC | 0.046 | 0.2 |
| mRNA | 1S,3R-RSL-3 | CTRPv2 | pan-cancer | AAC | -0.043 | 0.2 |
| mRNA | BRD-K37390332 | CTRPv2 | pan-cancer | AAC | -0.05 | 0.2 |
| mRNA | staurosporine | CTRPv2 | pan-cancer | AAC | -0.092 | 0.2 |
| mRNA | RO4929097 | CTRPv2 | pan-cancer | AAC | 0.068 | 0.2 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | 0.047 | 0.2 |
| mRNA | AZD-7545 | CTRPv2 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | UNC0638:navitoclax (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.047 | 0.2 |